Free Trial

20 Stocks to Sell Now - 19 of 20

 
 

Solventum (NYSE:SOLV)

Consensus Rating
Reduce
Rating Score
1.9
Ratings Breakdown
0 Buy Ratings, 7 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$58.25 (14.0% Downside)

About Solventum

Solventum logoSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
9/26/2024Wolfe ResearchInitiated CoveragePeer Perform
9/5/2024BTIG ResearchInitiated CoverageNeutral
8/12/2024The Goldman Sachs GroupBoost Price TargetSell ➝ Sell$48.00 ➝ $54.00
8/9/2024Wells Fargo & CompanyLower Price TargetEqual Weight ➝ Equal Weight$69.00 ➝ $64.00
7/15/2024Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$70.00 ➝ $55.00
7/10/2024The Goldman Sachs GroupLower Price TargetSell ➝ Sell$54.00 ➝ $48.00
6/25/2024Bank of AmericaLower Price TargetNeutral ➝ Neutral$70.00 ➝ $60.00
6/24/2024ArgusInitiated CoverageHold
5/30/2024The Goldman Sachs GroupInitiated CoverageSell$54.00
5/10/2024Bank of AmericaInitiated CoverageNeutral$70.00
 

Next opportunity for crypto millions (Ad)

October isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run in history. And I've found the rocket fuel… One coin is quietly positioning itself to outperform the entire market. The signs are everywhere…

Go here to discover the coin that could define this historic bull run with gains kicking off this mo